Next-Generation Biological Fluid Processing Systems
Legal Citation
Summary of the Inventive Concept
A paradigm shift in biological fluid processing, integrating machine learning, wearable technology, and real-time analytics to revolutionize fluid balance monitoring and control.
Background and Problem Solved
The original patent disclosed systems and methods for monitoring and controlling fluid balance in medical procedures, but limitations in real-time data analysis and treatment personalization hindered its potential. The new inventive concept addresses these limitations by introducing advanced technologies to provide more accurate, personalized, and efficient fluid balance management.
Detailed Description of the Inventive Concept
The next-generation biological fluid processing system comprises a machine learning module to predict optimal fluid volumes based on patient medical history and treatment data. A wearable, portable light source for extracorporeal photopheresis enables real-time monitoring and treatment. A nanofiltration module removes unwanted cellular components, and a microfluidic channel analyzes fluid composition in real-time. The system integrates with a database of genomic profiles to predict optimal treatment protocols and provide real-time feedback. In vivo monitoring of fluid balance is achieved through implantable micro-sensors, transmitting data to a remote server for analysis and feedback.
Novelty and Inventive Step
The new inventive concept's integration of machine learning, wearable technology, and real-time analytics provides a novel and non-obvious solution for biological fluid processing, surpassing the original patent's limitations and enabling more accurate, personalized, and efficient fluid balance management.
Alternative Embodiments and Variations
Alternative embodiments may include using different machine learning algorithms, varying the type of wearable technology, or incorporating additional sensors for in vivo monitoring. Variations may also include adapting the system for use in different medical procedures or integrating with other medical devices.
Potential Commercial Applications and Market
The next-generation biological fluid processing system has significant commercial potential in the medical device industry, particularly in the fields of hematology, oncology, and personalized medicine. The system's ability to provide real-time, personalized fluid balance management can improve treatment outcomes, reduce healthcare costs, and enhance patient quality of life.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61M1/3607 |
| A | A61 | A61M1/0209 |
| A | A61 | A61M1/361 |
| A | A61 | A61M1/3643 |
| A | A61 | A61M1/3672 |
| A | A61 | A61M1/3683 |
| A | A61 | A61M1/3693 |
| A | A61 | A61M1/3696 |
| A | A61 | A61M1/38 |
| A | A61 | A61M2202/0092 |
| A | A61 | A61M2202/0407 |
| A | A61 | A61M2202/0413 |
| A | A61 | A61M2202/0415 |
| A | A61 | A61M2202/0429 |
| A | A61 | A61M2202/0439 |
| A | A61 | A61M2202/0443 |
| A | A61 | A61M2205/3386 |
| A | A61 | A61M2205/50 |
| A | A61 | A61M2230/005 |
| A | A61 | A61M2230/207 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical fluid processing technologies, specifically blood separation and treatment systems, involving complex medical device engineering, fluid dynamics, and biomedical instrumentation with expertise in centrifugation, pump systems, and cellular processing techniques
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device specialist with advanced degree, working knowledge of fluid processing technologies, understanding of medical device control systems, machine learning applications in medical contexts, and familiarity with emerging sensor and monitoring technologies
Obviousness Rationale
A PHOSITA would recognize that the PTD's machine learning and real-time monitoring extensions represent predictable technological improvements to the source patent's fluid processing framework. The core fluid separation and control mechanisms remain fundamentally consistent, with the PTD introducing incremental enhancements in data analysis, personalization, and monitoring capabilities. These variations represent natural technological progressions enabled by advances in computational and sensor technologies.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,714 |
|---|---|
| Title | Systems and methods for monitoring and controlling fluid balance during a biological fluid procedure |
| Assignee(s) | Fenwal, Inc. |